BioNTech SE (BNTX) Change in Inventory (2018 - 2025)
BioNTech SE (BNTX) reported Change in Inventory of $135.3 million for Q4 2025, up 536.08% on a YoY basis from $21.3 million in Q4 2024, and up 2168.66% sequentially from $6.0 million in Q3 2025.
BioNTech SE (BNTX) Change in Inventory (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Change in Inventory data on file, last reported at $135.3 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory rose 536.08% year-over-year to $135.3 million; the trailing twelve-month figure through Dec 2025 stood at $202.6 million (up 150.2% YoY), and the FY2025 full-year result was $201.0 million, up 152.47% from the prior year.
- Change in Inventory advanced to $135.3 million in Q4 2025, from $6.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $135.3 million in Q4 2025 to a low of -$388.3 million in Q3 2021.
- A 5-year average of -$13.0 million and a median of $19.0 million in 2023 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory slumped 212329714.98% in 2021 and jumped 48545115.36% in 2022, its largest moves.
- Tracing BNTX's Change in Inventory over 5 years: stood at -$124.8 million in 2021, then decreased by 18.37% to -$147.7 million in 2022, then jumped by 142.24% to $62.4 million in 2023, then sank by 65.92% to $21.3 million in 2024, then jumped by 536.08% to $135.3 million in 2025.
- Business Quant data shows BNTX's Change in Inventory at $135.3 million in Q4 2025, $6.0 million in Q3 2025, and $25.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | 135.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 135.26 Mn |
| Dec 31, 2025 | 135.26 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Jun 30, 2025 | 25.81 Mn |
| Jun 30, 2025 | 25.81 Mn |
| Mar 31, 2025 | 35.55 Mn |
| Mar 31, 2025 | 35.55 Mn |
| Dec 31, 2024 | 21.27 Mn |
| Dec 31, 2024 | 21.27 Mn |
| Sep 30, 2024 | 40.63 Mn |
| Sep 30, 2024 | 40.63 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 13.36 Mn |
| Mar 31, 2024 | 13.36 Mn |
| Dec 31, 2023 | 62.40 Mn |
| Dec 31, 2023 | 62.40 Mn |
| Sep 30, 2023 | 36.14 Mn |
| Sep 30, 2023 | 36.14 Mn |